Intracardiac Echocardiography for Safer Left Atrial Appendage Occlusion

Left atrial appendage occlusion (LAAO) is an established transcatheter option for selected patients with non-valvular atrial fibrillation who have a substantial risk of stroke and a compelling reason to avoid long-term oral anticoagulation. The procedure depends on accurate imaging at every stage, from pre-procedural anatomical assessment to device release and follow-up.

Intracardiac echocardiography (ICE) has become an important alternative to transoesophageal echocardiography (TEE) in many structural heart and electrophysiology laboratories. A catheter-based ultrasound probe can provide real-time views from within the right atrium, left atrium, or pulmonary artery, helping operators guide transseptal puncture, assess the appendage, and identify complications.

The safety value of ICE extends beyond image acquisition. It may allow selected cases to proceed with conscious sedation rather than general anaesthesia, reduce reliance on oesophageal intubation, and support a more streamlined workflow. These advantages must be balanced against the need for operator expertise, equipment availability, vascular access, and a clear response plan when imaging is incomplete.

For Australian centres, the choice between ICE and TEE is shaped by local staffing, public and private hospital pathways, device procurement, anaesthetic resources, and the distance patients may travel for specialist care. A careful protocol can make the technique reproducible while preserving the safeguards expected in contemporary electrophysiology.

Why imaging determines procedural safety

The left atrial appendage has highly variable morphology, orientation, depth, and ostial dimensions. Lobes can be missed on a single imaging plane, while trabeculations and pectinate muscles may resemble thrombus. Pre-procedural cardiac CT or TEE is therefore commonly used to exclude thrombus, measure the landing zone, and select an appropriately sized occluder.

During the intervention, imaging confirms that the delivery sheath is positioned safely and that the device is stable before release. ICE can visualise the interatrial septum, guide puncture at a suitable posterior-inferior location, and help monitor the relationship between the device and nearby structures. It may also show pericardial fluid, left atrial dissection, device embolisation, or interference with the mitral valve.

The principal safety objective is to detect a problem early enough to correct it. A shallow device may have inadequate anchoring; excessive oversizing may cause compression, deformation, or tissue injury. Colour Doppler can help assess peri-device flow, although the interpretation of residual leak depends on the device, imaging angle, timing, and local protocol.

ICE compared with transoesophageal echocardiography

TEE remains a familiar and valuable standard for LAAO. It offers high-resolution multiplanar imaging and can provide detailed assessment of thrombus, device compression, peri-device leak, and pericardial effusion. It is especially useful when anatomy is complex or when pre-procedural imaging raises concern about thrombus or an unusual appendage orientation.

ICE avoids oesophageal instrumentation and may reduce the need for general anaesthesia. Patients can potentially recover sooner, and the laboratory may require fewer anaesthetic resources. This can be relevant in busy metropolitan hospitals in Sydney, Melbourne, Brisbane, Perth, and Adelaide, where access to dedicated theatre and anaesthesia time can affect scheduling.

The comparison is not simply a choice between “less invasive” and “more invasive” imaging. ICE requires venous access, catheter manipulation, image interpretation, and a trained team able to recognise limitations. TEE may be preferable when the patient cannot tolerate prolonged supine positioning, when comprehensive oesophageal imaging is essential, or when the team has greater experience with TEE than with intracardiac ultrasound.

A safety-focused procedural workflow

A structured ICE workflow begins before vascular access. The team should review CT or TEE findings, document the suspected appendage morphology, confirm the absence of thrombus according to local policy, and plan the transseptal trajectory. Anticoagulation management should be explicit, including the timing of heparin, activated clotting time targets, and post-procedure antithrombotic therapy.

After venous access, ICE can help identify the fossa ovalis and guide transseptal puncture under direct visual control. The operator should maintain awareness of the needle tip and sheath position rather than relying on pressure changes or fluoroscopy alone. Once in the left atrium, the catheter may provide views of the appendage and device from multiple angles, though image quality can vary with probe position and cardiac motion.

Before release, the team should confirm stable anchoring, satisfactory depth, appropriate compression, absence of significant peri-device flow, and no obstruction of adjacent structures. A final survey for pericardial effusion is essential. Haemodynamic instability, unexpected resistance, loss of wire position, or an unclear device profile should prompt a pause rather than an immediate release.

Complications ICE can help detect

Pericardial effusion and tamponade are among the most serious complications of transseptal structural procedures. They may result from puncture, catheter manipulation, guidewire movement, or device deployment. ICE can identify new fluid and track its progression, supporting rapid escalation to drainage, reversal of anticoagulation where appropriate, or surgical consultation.

Vascular complications remain relevant because ICE adds a large-bore venous catheter to the procedural setup. Femoral bleeding, haematoma, pseudoaneurysm, arteriovenous fistula, and venous thrombosis should be addressed through careful access technique, ultrasound-guided puncture, appropriate closure strategy, and post-procedure observation. The additional catheter should be included in the access and haemostasis plan from the beginning.

Device embolisation, incomplete deployment, and peri-device leak require prompt recognition. ICE may show abnormal device mobility or a change in position, although fluoroscopy and TEE may be needed to clarify the finding. Stroke prevention also depends on avoiding air entry, maintaining adequate anticoagulation, managing thrombus on equipment, and minimising unnecessary catheter exchanges.

Training, equipment, and Australian practice

Safe ICE use requires more than purchasing a console and probe. Operators need supervised experience in standard views, probe manipulation, catheter orientation, Doppler interpretation, and recognition of artefacts. The wider team should rehearse management of tamponade, device embolisation, major bleeding, contrast reactions, and emergency conversion to surgery.

Australian services may face different practical conditions. A tertiary public hospital in Melbourne may have established structural heart imaging support, while a regional centre in New South Wales or Queensland may need visiting expertise, telehealth planning, or referral pathways for complex cases. Workforce availability, after-hours cover, and the cost of single-use imaging catheters can influence whether ICE is used routinely or selectively.

Device access and funding arrangements also vary between hospitals and patient pathways. Teams should account for local Therapeutic Goods Administration requirements, hospital procurement policies, credentialling standards, and any relevant Medicare or private-insurance arrangements rather than assuming that an approach used overseas transfers directly to Australian practice. The patient’s travel burden matters too, particularly when follow-up imaging requires a return trip from rural or remote communities.

LAAO should sit within a broader atrial fibrillation service. Assessment of stroke risk, bleeding risk, rhythm control, heart failure, renal function, and future anticoagulation needs remains essential. Readers reviewing procedural imaging alongside rhythm management may find related discussion in ablation in HFrEF, particularly when considering how structural and electrophysiology decisions interact.

Evidence gaps and future directions

Studies comparing ICE-guided and TEE-guided LAAO suggest that ICE can achieve high procedural success with fewer requirements for general anaesthesia in selected patients. However, much of the evidence comes from experienced centres, observational cohorts, or protocols with different devices and imaging definitions. Results may therefore reflect institutional skill as well as the technology itself.

Important questions remain about the learning curve, cost-effectiveness, contrast use, radiation exposure, and the best approach for patients with complex appendage anatomy. The quality of pre-procedural CT may influence how safely a team can rely on ICE during the intervention. Comparative research should also report patient-centred outcomes such as recovery time, post-procedure discomfort, unplanned admission, and quality of life.

Artificial intelligence-assisted image interpretation, three-dimensional ICE, and smaller steerable probes may improve anatomical visualisation. These developments will be most useful when paired with standardised reporting and robust training. A technology should be judged by whether it reduces preventable complications and improves care across different hospitals, rather than by image quality alone.

For clinicians, researchers, and trainees, peer-reviewed updates are available through the Journal of Arrhythmia, including work on ablation, pacing, implantable devices, pharmacology, and procedural electrophysiology. Sharing outcomes from Australian practice can help clarify how intracardiac echocardiography performs across metropolitan, regional, public, and private settings.

A safe LAAO programme combines appropriate patient selection, reliable pre-procedural imaging, disciplined anticoagulation, skilled ICE manipulation, and immediate access to complication management. Australian teams can strengthen this approach by developing shared protocols, auditing outcomes, and contributing local data to the international arrhythmia community. Explore current evidence and submit practice-changing research to support safer, more consistent left atrial appendage occlusion.